Higher Scientific Officer (Maternity Leave) - Glioma Team

11/01/2019, 23:55

Molecular Pathology
Glioma Team
Full time
Temporary Contract
10 months
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The Glioma Team is focused on understanding the biology of paediatric glioblastoma (pGBM) and diffuse intrinsic pontine glioma (DIPG) such that we may improve the clinical outcome of children with these currently untreatable tumours. We have expertise in genomics and molecular cell biology of the human disease, and use this knowledge to design and test new drug treatments in novel mouse models.


We are looking for maternity leave cover for 10 months for a Higher Scientific Officer in our laboratory from 1stFebruary – 30thNovember 2019. The post holder may be involved with a range of ongoing molecular cell biology experiments, but would particularly play an important role in histological processing of tissue for pathology and molecular analysis. The successful candidate will ideally have experience in embedding, cutting and staining tissue, as well as immunohistochemical / immunofluorescence techniques. 


Appropriate laboratory experience and a First or Upper Second Class honours degree in a relevant subject is essential, with knowledge or interest in childhood brain tumours an advantage. 

We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.
Additional Documentation for Candidates

This Program is closed to applications.